Liver Fibrosis in the Rising Epidemic of Fatty Liver Disease: Prevention and Treatment.

Low-dose levothyroxine reduces intrahepatic lipid content in patients with type 2 diabetes mellitus and NAFLD

E Bruinstroop, R Dalan, Y Cao, YM Bee, K Chandran, LW Cho, SB Soh, EK Teo, SA Toh, MKS Leow, RA Sinha, SA Sadananthan, N Michael, HM Stapleton, C Leung, PW Angus, SK Patel, LM Burrell, SC Lim, CF Sum

2018-07-01

Context Nonalcoholic fatty liver disease (NAFLD) is highly prevalent in patients with type 2 diabetes mellitus (T2DM) and associat..

Glycation: A new hope in targeting hepatocellular carcinoma?

C Leung, PW Angus, JM Forbes

2017-12-01

Hepatocellular carcinoma (HCC) is the second most common cause of cancer mortality worldwide and is the most rapidly growing indic..

The role of the gut microbiota in NAFLD

C Leung, L Rivera, JB Furness, PW Angus

2016-07-01

NAFLD is now the most common cause of liver disease in Western countries. This Review explores the links between NAFLD, the metabo..